U.S. and state officials say the consolidation of the public health agency’s vast trove of information could expose patients ...

C3.ai is overcoming some of its biggest near-term challenges. Palantir's growth rates are impressive, but its valuations could be unsustainable. C3.ai's AI modules can be installed as on-premises ...

Valuation concerns persist, but Palantir's innovation ... a large amount of sensitive data always has potential legal and reputational risks if any private or security breaches occur.

Discover insights on Palantir's valuation, growth challenges, and AI-software moat. Learn why it may be time to reassess your ...

Palantir Technologies Inc. (NASDAQ: PLTR) shares are trading lower Thursday after backlash from Republican lawmakers over the ...

Palantir Technologies (NASDAQ: PLTR) has emerged as the Trump administration’s primary data analysis partner based on recent ...

The Trump administration has reportedly been discreetly working with Palantir Technologies Inc. (NASDAQ: PLTR) to gather ...

Palantir has received more than $113 million in federal funds since Trump took office and is reportedly discussing potential ...

Palantir has built its reputation on two primary platforms ... Palantir’s stock is part of a broader AI bubble. Several concerns underpin this argument: A significant critique levied at Palantir ...

With its reputation as a cutting ... or broader economic concerns, the stock’s lofty valuation could come under pressure. Palantir Technologies has been delivering solid revenue growth, soaring ...

The Trump administration reportedly wants a master database on every American — and they want Palantir to make it happen.

Palantir (PLTR) stock fell 1.6% Friday and posted a 5.6% decline for the trading week amid continued concerns about the company's lofty valuation. Shares of Palantir fell 12% Tuesday, shaving just ...